0901 b 803802371 b 6

Embed Size (px)

Citation preview

  • 8/9/2019 0901 b 803802371 b 6

    1/4

    Plastics

    Eur

    ope

    Next Generation Collation Shrink FilmSolutions from Dow

    Colla

    tionShrinkFilms

    Collation shrink packaging is one of the

    fastest-growing segments within the

    European and global packaging industries.

    The reasons are many:

    Environmental concerns over resource depletion

    (i.e., forests), energy consumption, post-consumer

    waste and more associated with traditional

    packaging

    Trends toward bulk warehouse shopping

    and multi-pack packaging

    Desire to combine shipping packaging with

    display packaging for cost savings

    Achieve cost efficiencies by reducing

    costlier paperboard packaging and printing

    Create see-through packaging

    to promote branding

    As film converters and end users seek new

    ways to make collation shrink work even more

    efficiently for them, several specific needs

    become as clear as the films they desire:

    Need to downgauge films to below 45 microns for

    average-sized multi-packs Need for high gloss/low haze films to achieve ex-

    cellent shelf appeal

    Trademark of The Dow Chemical Company

    Need for films capable of high-speed machining

    Need for coex films to achieve both ease of

    printing and appeal, while also fulfilling strength

    and sealability issues

    Need for excellent uniform shrink around

    product form

    Need for balance between films strength and

    customers ease of opening

    Need for product differentiation potential in

    film products

    Need to reduce costs for packaging

    Whats equally clear is that Dow is well-suited

    to answer these needs. Consider Dows

    strength in LDPE and LLDPE resins, the two

    major resins utilized within the shrink market.

    Then, add in Dows extensive knowledge of

    coextrusion films and its history for creating

    perfect fits for specific industries.

  • 8/9/2019 0901 b 803802371 b 6

    2/4

  • 8/9/2019 0901 b 803802371 b 6

    3/4

    Features & BenefitsCombining excellent optics and shrinkage with a

    choice of stiffness and abuse resistance, thesepackaging solutions offer an attractive way for

    converters and brand owners to maximize the

    benefits of collation shrink film products.

    Gloss

    In lab testing, versus existing competitive market

    samples, selected Dow solutions based on the

    herein listed resins demonstrated 15-20%

    improvements in gloss. Such improved gloss

    could add eye-catching sparkle and shine to

    boost shelf appeal and customer awareness.

    Haze

    Haze is an unwanted aspect of film packaging

    in general. Thus, the 30-40% reduction in haze

    compared to the existing market samples should

    be welcome news to every converter and packer!

    Together with the improved gloss, Dow shrink

    film formulations can offer excellent optics the

    key to stunning film packaging.

    Controlled Shrinkage

    Overall Dow shrink film resins deliver anadequate level of orientability and thus can

    yield films with a high level of Machine Direction

    (MD) shrinkage above 65% and adjustable

    Cross Direction (CD) shrink rates. High shrink

    tension levels in Dow formulated films allow

    for exceptional package integrity and can be

    used in numerous collation and overwrap

    shrink applications.

    Stiffness

    Because packagers may desire different textures

    for different packaging applications, Dowsshrink film formulations can be fine tuned for

    targeted stiffness levels, which provide a large

    space for todays trendy downgauging.

    For example, stiffness (measured in MPa per

    2% secant modulus) can, in Dow films, range

    from less than 200 MPa (soft and conformable

    films) to nearly 300 MPa (excellent down-

    gauging ability).

    Converters and brand owners can turn to a single

    source Dow for these solutions.

    ConclusionsThe benefits are many for converters and

    brand owners alike, and they lead to valuableconclusions for both as well.

    For film converters, these shrink solutions

    from Dow offer consistent, high-quality LDPE/

    LLDPE films capable of significantly advancing

    the most important qualities of shrink wrap

    creating potential for higher value and differenti-

    ation of their products to their customers.

    For brand owners, clearer films with eye-popping

    graphics capabilities can create desirable

    eye magnetism for the collated products. And,

    the films balance between packaging strength

    and consumers ease of opening can benefit

    everyone along the supply chain. Finally, these

    solutions allow brand owners to confront todays

    tough environmental issues by reducing natural

    resource consumption and post-consumer waste,

    while lowering resin and energy consumption in

    creating the packaging.

    Available NowAll presented resins are available today to all

    Dow customers for sampling and testing in anytype of collation shrink and industrial shrink

    film structures.

    Please consult with your Dow specialist for

    any specific requests on performance and

    formulation.

    Benefits for Film Converters

    Improved Film Performance

    Step-change improvements in gloss andhaze performance

    Excellent mechanical strength and

    processability

    Simplified Operation

    One-stop supplier capabilities

    Easy processability and proven support

    Reduced Costs

    Potential to downgauge and lower resin

    consumption

    Improved Value

    Opportunities for differentiation

    Benefits for Brand Owners

    Package Differentiation

    High gloss and sparkle create appeal

    Greater definition in printing allows

    sophisticated graphics

    Clarity offers good see-through brand

    identification and recognition

    Reduced Breakage Tough mechanical properties increase

    holding force to decrease breakage

    and waste

    Lower Packaging Costs

    Potential to downgauge films

    Potential to reduce overall packaging

    Address Environmental Issues

    Potential reduction in other packaging

    materials, reducing post-consumer waste

    Trademark of The Dow Chemical Company (Dow)or an affiliated company of Dow

    Strength

    Impact strength and tear resistance are among

    the most important aspects of collation shrinkpackaging. How the film reacts to potential

    punctures and stresses determines its final pro-

    tective packaging success. Dows proposed film

    structures based on DOWLEX and DOW LDPE

    resins deliver excellent performance in terms

    of both impact strength and tear resistance.

  • 8/9/2019 0901 b 803802371 b 6

    4/4

    For more information on products, innovations, expertise, and other services availableto you from Dows Plastics business group, visit www.dowplastics.com and choose yourregion, or contact us as indicated below.

    Trademark of The Dow Chemical Company (Dow) or an affiliated company of DowResponsible Care is a service mark of the American Chemistry Council.Dow is a partner in the American Chemistry Council Responsible Care initiative. Form No. 784-00701-0309X SMG SMG 11723

    North America

    U.S. & Canada 1-800-441-4369

    1-989-832-1426

    Mexico +1-800-441-4369

    Latin America

    Argentina +54-11-4319-0100

    Brazil +55-11-5188-9000

    Colombia +57-1-219-6000

    Mexico +52-55-5201-4700

    Europe/Middle East +800-3694-6367

    +32-3-450-2240

    Italy +800-783-825

    South Africa +800-99-5078

    Asia Pacific +800-7776-7776

    +603-7965-5392

    The principles of Responsible Careand Sustainable Development influence the production of printed literaturefor The Dow Chemical Company (Dow). As a contribution towards the protection of our environment, Dowsprinted literature is produced in small quantities and on paper containing recovered/post-consumer fiber andusing 100 percent soy-based ink whenever possible.

    NOTICE: Any photographs of end-use applications in this document represent potential end-use applicationsbut do not necessarily represent current commercial applications, nor do they represent an endorsement byDow of the actual products. Further, these photographs are for illustration purposes only and do not reflect eitheran endorsement or sponsorship of any other manufacturer for a specific potential end-use product or application,or for Dow, or for specific products manufactured by Dow.

    NOTICE: No freedom from infringement of any patent owned by Dow or others is to be inferred. Because useconditions and applicable laws may differ from one location to another and may change with time, the Customeris responsible for determining whether products and the information in this document are appropriate for theCustomers use and for ensuring that the Customers workplace and disposal practices are in compliance withapplicable laws and other governmental enactments. Dow assumes no obligation or liability for the informationin this document. NO WARRANTIES ARE GIVEN; ALL IMPLIED WARRANTIES OF MERCHANTABILITYOR FITNESS FOR A PARTICULAR PURPOSE ARE EXPRESSLY EXCLUDED.

    NOTICE: If products are described as experimental or developmental: (1) product specifications may not be

    fully determined; (2) analysis of hazards and caution in handling and use are required; (3) there is greater potentialfor Dow to change specifications and/or discontinue production; and (4) although Dow may from time to timeprovide samples of such products, Dow is not obligated to supply or otherwise commercialize such products forany use or application whatsoever.

    NOTICE REGARDING MEDICAL APPLICATION RESTRICTIONS: Dow will not knowingly sell or sample any productor service (Product) into any commercial or developmental application that is intended for:a. long-term or permanent contact with internal bodily fluids or tissues. Long-term is contact which exceeds

    72 continuous hours;b. use in cardiac prosthetic devices regardless of the length of time involved (cardiac prosthetic devices

    include, but are not limited to, pacemaker leads and devices, artificial hearts, heart valves, intra-aorticballoons and control systems, and ventricular bypass-assisted devices);

    c. use as a critical component in medical devices that support or sustain human life; ord. use specifically by pregnant women or in applications designed specifically to promote or interfere with

    human reproduction.

    Dow requests that customers considering use of Dow products in medical applications notify Dow so thatappropriate assessments may be conducted.

    Dow does not endorse or claim suitability of its products for specific medical applications. It is the responsibilityof the medical device or pharmaceutical manufacturer to determine that the Dow product is safe, lawful, andtechnically suitable for the intended use. DOW MAKES NO WARRANTIES, EXPRESS OR IMPLIED,CONCERNING THE SUITABILITY OF ANY DOW PRODUCT FOR USE IN MEDICAL APPLICATIONS.

    This document is intended for use within EuropePublished March, 2009. Printed in Switzerland. 2009 The Dow Chemical Company